Yan Jie, Mao Ya-Fei
Department of Medical Microbiology and Parasitology, College of Medical Science, Zhejiang University, 353 Yan An Road, Hangzhou 310031, Zhejiang Province, China.
World J Gastroenterol. 2004 Apr 1;10(7):985-90. doi: 10.3748/wjg.v10.i7.985.
To construct a recombinant prokaryotic expression vector inserted with Helicobacter pylori vacA gene and identify the immunity of the expressed recombinant protein, and to determine prevalence of vacA-carrying/VacA expressing H pylori isolates and seroprevalence of specific ant-VacA antibody in H pylori infected patients.
Polymerase chain reaction technique was used to amplify complete vacA gene of H pylori strain NCTC11637 and to detect vacA gene in 109 H pylori isolates. The amplification product of the complete vacA gene was sequenced after T-A cloning. A recombinant expression vector inserted with a complete vacA gene fragment, named as pET32a-vacA, was constructed. Expression of the target recombinant protein VacA (rVacA) was examined by SDS-PAGE. Western blot using commercial antibodies against whole cell of H pylori and an immunodiffusion assay using self-prepared rabbit anti-rVacA antibody were applied to determine immunoreaction and antigenicity of rVacA. Two ELISA methods were established to detect VacA expression in H pylori isolates and the specific anti-VacA antibody in sera from 125 patients infected with H pylori.
In comparison with the reported corresponding sequences, homologies of nucleotide and putative amino acid sequences of the cloned vacA gene were 99.82% and 100%, respectively. The constructed recombinant prokaryotic expression system efficiently produced rVacA. rVacA was able to combine with the commercial antibodies against whole cell of H pylori and to induce the immunized rabbit to produce specific antibody with an immunodiffusion titer of 1:4. All tested H pylori isolates carried vacA gene, but only 66.1% expressed VacA protein. Of the serum samples tested, 42.4% were positive for specific anti-VacA antibody.
A prokaryotic expression system of H pylori vacA gene was successfully constructed. The expressed rVacA can be used to detect specific anti-VacA antibody in human and to prepare antiserum in animals. The high frequency of vacA gene in H pylori isolates, but with a low frequency of VacA expression and specific anti-VacA antibody in H pylori infected patients implies that VacA is not an ideal antigen for H pylori vaccine.
构建插入幽门螺杆菌vacA基因的重组原核表达载体,鉴定表达的重组蛋白的免疫活性,确定携带vacA基因/表达VacA的幽门螺杆菌分离株的流行情况以及幽门螺杆菌感染患者中抗VacA特异性抗体的血清流行率。
采用聚合酶链反应技术扩增幽门螺杆菌菌株NCTC11637的完整vacA基因,并检测109株幽门螺杆菌分离株中的vacA基因。T-A克隆后对完整vacA基因的扩增产物进行测序。构建插入完整vacA基因片段的重组表达载体,命名为pET32a-vacA。通过SDS-PAGE检测目标重组蛋白VacA(rVacA)的表达。使用针对幽门螺杆菌全细胞的商业抗体进行Western印迹以及使用自制的兔抗rVacA抗体进行免疫扩散试验,以确定rVacA的免疫反应性和抗原性。建立两种ELISA方法检测幽门螺杆菌分离株中VacA的表达以及125例幽门螺杆菌感染患者血清中的抗VacA特异性抗体。
与报道的相应序列相比,克隆的vacA基因的核苷酸和推定氨基酸序列的同源性分别为99.82%和100%。构建的重组原核表达系统高效产生rVacA。rVacA能够与针对幽门螺杆菌全细胞的商业抗体结合,并诱导免疫兔产生免疫扩散效价为1:4的特异性抗体。所有检测的幽门螺杆菌分离株均携带vacA基因,但只有66.1%表达VacA蛋白。在所检测的血清样本中,42.4%的抗VacA特异性抗体呈阳性。
成功构建了幽门螺杆菌vacA基因的原核表达系统。表达的rVacA可用于检测人血清中的抗VacA特异性抗体,并用于制备动物抗血清。幽门螺杆菌分离株中vacA基因的高频率存在,但VacA表达频率低以及幽门螺杆菌感染患者中抗VacA特异性抗体频率低,这意味着VacA不是幽门螺杆菌疫苗的理想抗原。